226 related articles for article (PubMed ID: 35856412)
1. Functions and mechanisms of N6‑methyladenosine in prostate cancer (Review).
Wan H; Feng Y; Wu J; Zhu L; Mi Y
Mol Med Rep; 2022 Sep; 26(3):. PubMed ID: 35856412
[TBL] [Abstract][Full Text] [Related]
2. Role of N
Pan J; Tong F; Ren N; Ren L; Yang Y; Gao F; Xu Q
Oncol Rep; 2024 Jun; 51(6):. PubMed ID: 38757383
[TBL] [Abstract][Full Text] [Related]
3. RNA m
Han Z; Yi X; Li J; Zhang T; Liao D; You J; Ai J
Biochim Biophys Acta Rev Cancer; 2023 Sep; 1878(5):188961. PubMed ID: 37507057
[TBL] [Abstract][Full Text] [Related]
4. YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer.
Li J; Xie H; Ying Y; Chen H; Yan H; He L; Xu M; Xu X; Liang Z; Liu B; Wang X; Zheng X; Xie L
Mol Cancer; 2020 Oct; 19(1):152. PubMed ID: 33121495
[TBL] [Abstract][Full Text] [Related]
5. m
Lang C; Yin C; Lin K; Li Y; Yang Q; Wu Z; Du H; Ren D; Dai Y; Peng X
Clin Transl Med; 2021 Jun; 11(6):e426. PubMed ID: 34185427
[TBL] [Abstract][Full Text] [Related]
6. Epigenetics-based diagnostic and therapeutic strategies: shifting the paradigm in prostate cancer.
Clermont PL
Epigenomics; 2023 Jan; 15(2):75-87. PubMed ID: 36974615
[TBL] [Abstract][Full Text] [Related]
7. Epigenetics-related genes in prostate cancer: expression profile in prostate cancer tissues, androgen-sensitive and -insensitive cell lines.
Adler D; Lindstrot A; Ochsenfahrt J; Fuchs K; Wernert N
Int J Mol Med; 2013 Jan; 31(1):21-5. PubMed ID: 23135352
[TBL] [Abstract][Full Text] [Related]
8. The epigenetics of prostate cancer diagnosis and prognosis: update on clinical applications.
Blute ML; Damaschke NA; Jarrard DF
Curr Opin Urol; 2015 Jan; 25(1):83-8. PubMed ID: 25405932
[TBL] [Abstract][Full Text] [Related]
9. Silencing of METTL3 effectively hinders invasion and metastasis of prostate cancer cells.
Chen Y; Pan C; Wang X; Xu D; Ma Y; Hu J; Chen P; Xiang Z; Rao Q; Han X
Theranostics; 2021; 11(16):7640-7657. PubMed ID: 34335955
[No Abstract] [Full Text] [Related]
10. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
11. Lipid Metabolism and Epigenetics Crosstalk in Prostate Cancer.
Pardo JC; Ruiz de Porras V; Gil J; Font A; Puig-Domingo M; Jordà M
Nutrients; 2022 Feb; 14(4):. PubMed ID: 35215499
[TBL] [Abstract][Full Text] [Related]
12. Molecular diagnosis of prostate cancer: are we up to age?
Bhavsar T; McCue P; Birbe R
Semin Oncol; 2013 Jun; 40(3):259-75. PubMed ID: 23806492
[TBL] [Abstract][Full Text] [Related]
13. Using Genetic and Epigenetic Markers to Improve Differential Diagnosis of Prostate Cancer and Benign Prostatic Hyperplasia by Noninvasive Methods in Mexican Patients.
Sánchez BE; Aguayo A; Martínez B; Rodríguez F; Marmolejo M; Svyryd Y; Luna L; Muñoz LA; Jiménez MA; Sotomayor M; Vargas V F; Mutchinick OM
Clin Genitourin Cancer; 2018 Aug; 16(4):e867-e877. PubMed ID: 29571584
[TBL] [Abstract][Full Text] [Related]
14. DNA hypermethylation associated with upregulated gene expression in prostate cancer demonstrates the diversity of epigenetic regulation.
Rauluseviciute I; Drabløs F; Rye MB
BMC Med Genomics; 2020 Jan; 13(1):6. PubMed ID: 31914996
[TBL] [Abstract][Full Text] [Related]
15. [Long non-coding RNAs in prostate cancer: An update].
Wu PG; Zhang YX
Zhonghua Nan Ke Xue; 2018 Aug; 24(8):735-739. PubMed ID: 30173435
[TBL] [Abstract][Full Text] [Related]
16. GPM6B Inhibit PCa Proliferation by Blocking Prostate Cancer Cell Serotonin Absorptive Capacity.
He S; Huang Z; Li X; Ding Y; Sheng H; Liu B; Jia Z
Dis Markers; 2020; 2020():8810756. PubMed ID: 33294057
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic targets in the diagnosis and treatment of prostate cancer.
Manoharan M; Ramachandran K; Soloway MS; Singal R
Int Braz J Urol; 2007; 33(1):11-8. PubMed ID: 17335593
[TBL] [Abstract][Full Text] [Related]
18. New insights into lipid metabolism and prostate cancer (Review).
Zhang Z; Wang W; Kong P; Feng K; Liu C; Sun T; Sang Y; Duan X; Tao Z; Liu W
Int J Oncol; 2023 Jun; 62(6):. PubMed ID: 37203395
[TBL] [Abstract][Full Text] [Related]
19. Aberrant
Bjerre MT; Strand SH; Nørgaard M; Kristensen H; Rasmussen AK; Mortensen MM; Fredsøe J; Mouritzen P; Ulhøi B; Ørntoft T; Borre M; Sørensen KD
Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30866497
[TBL] [Abstract][Full Text] [Related]
20. The role of genetic markers in the management of prostate cancer.
Choudhury AD; Eeles R; Freedland SJ; Isaacs WB; Pomerantz MM; Schalken JA; Tammela TL; Visakorpi T
Eur Urol; 2012 Oct; 62(4):577-87. PubMed ID: 22695242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
